Menu

1 / 22

CareCloud: The AI Payoff Shows Up In Margins, But Revenue Needs To Follow (Rating Downgrade)

All Articles on Seeking Alpha·about 21 hours ago
#nAA8UZmO
#seekingalpha#chart#million#seeking#alpha
Reading 0:00
15s threshold

Tech and Growth 3.77K Followers

Summary

I re-rate CareCloud neutral: the $2.80 FY 2027 target implies 7% upside after the Q3 rally; wait for FY 2027 guidance.

CCLD's Q3 revenue grew 9% to $34 million, while gross margin reached 50.5% and operating income more than doubled to $7 million.

Further upside depends on shrinking revenue bottoming and AI and RCM cross-selling into Medsphere's customer base sustaining high-quality margin expansion.

Pro forma revenue declines and capitalized development costs cloud margin quality; $37 million of debt versus $5 million of cash remains an overhang.

andresr/E+ via Getty Images

I first covered CareCloud (CCLD) back in late January this year, initiating my coverage with a buy rating and a 1-year price target of $4.3 when the stock was trading around $2.9 per share.

As

This article was written by

Tech and Growth 3.77K Followers

We're a long-only asset manager allocating into tech and growth asset classes.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.